Stevens Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-682
| Closed | -$370K | – | 238 |
|
|
2024
Q2 | $370K | Buy |
+682
| New | +$360K | 0.13% | 150 |
|
|
2024
Q1 | – | Sell |
-7,260
| Closed | -$3.42M | – | 293 |
|
|
2023
Q4 | $3.42M | Buy |
7,260
+4,584
| +171% | +$2.12M | 0.85% | 19 |
|
|
2023
Q3 | $1.17M | Sell |
2,676
-2,212
| -45% | -$1M | 0.34% | 78 |
|
|
2023
Q2 | $2.17M | Buy |
4,888
+2,018
| +70% | +$931K | 0.45% | 42 |
|
|
2023
Q1 | $1.32M | Buy |
2,870
+2,154
| +301% | +$1.03M | 0.33% | 44 |
|
|
2022
Q4 | $367K | Buy |
+716
| New | +$364K | 0.23% | 80 |
|
|
2022
Q3 | – | Sell |
-835
| Closed | -$403K | – | 150 |
|
|
2022
Q2 | $403K | Buy |
+835
| New | +$413K | 0.28% | 60 |
|
|
2022
Q1 | – | Sell |
-3,898
| Closed | -$1.81M | – | 259 |
|
|
2021
Q4 | $1.81M | Buy |
3,898
+2,454
| +170% | +$1.03M | 0.42% | 64 |
|
|
2021
Q3 | $538K | Buy |
+1,444
| New | +$549K | 0.23% | 89 |
|
|
2019
Q4 | – | Sell |
-39,716
| Closed | -$9.54M | – | 653 |
|
|
2019
Q3 | $9.54M | Sell |
39,716
-1,906
| -5% | -$522K | 0.86% | 22 |
|
|
2019
Q2 | $11.7M | Sell |
41,622
-4,227
| -9% | -$1.15M | 0.53% | 41 |
|
|
2019
Q1 | $13.2M | Buy |
+45,849
| New | +$13.3M | 0.56% | 40 |
|
|
2018
Q4 | – | Sell |
-44,798
| Closed | -$12.3M | – | 747 |
|
|
2018
Q3 | $12.3M | Sell |
44,798
-30,989
| -41% | -$8.04M | 0.45% | 60 |
|
|
2018
Q2 | $18M | Sell |
75,787
-43,867
| -37% | -$10.2M | 0.65% | 35 |
|
|
2018
Q1 | $26.3M | Buy |
+119,654
| New | +$28.1M | 1% | 11 |
|
|
2017
Q4 | – | Sell |
-19,501
| Closed | -$3.7M | – | 880 |
|
|
2017
Q3 | $3.7M | Sell |
19,501
-106,826
| -85% | -$20.3M | 0.14% | 201 |
|
|
2017
Q2 | $23.8M | Buy |
+126,327
| New | +$22.7M | 0.89% | 12 |
|
|
2016
Q4 | – | Sell |
-86,284
| Closed | -$10.8M | – | 931 |
|
|
2016
Q3 | $10.8M | Sell |
86,284
-55,338
| -39% | -$7.15M | 0.45% | 53 |
|
|
2016
Q2 | $18.6M | Buy |
141,622
+126,537
| +839% | +$17.3M | 0.74% | 22 |
|
|
2016
Q1 | $2.1M | Buy |
15,085
+5,427
| +56% | +$725K | 0.08% | 270 |
|
|
2015
Q4 | $1.35M | Sell |
9,658
-24,408
| -72% | -$3.36M | 0.05% | 360 |
|
|
2015
Q3 | $4.77M | Sell |
34,066
-110,915
| -77% | -$16.7M | 0.22% | 128 |
|
|
2015
Q2 | $23.8M | Buy |
144,981
+128,725
| +792% | +$20.6M | 0.86% | 15 |
|
|
2015
Q1 | $2.51M | Sell |
16,256
-206,997
| -93% | -$29.5M | 0.09% | 237 |
|
|
2014
Q4 | $28.1M | Buy |
+223,253
| New | +$27.6M | 0.95% | 15 |
|
|
2014
Q3 | – | Sell |
-148,284
| Closed | -$16M | – | 1061 |
|
|
2014
Q2 | $16M | Sell |
148,284
-18,141
| -11% | -$1.87M | 0.43% | 63 |
|
|
2014
Q1 | $16.6M | Buy |
+166,425
| New | +$15.1M | 0.45% | 65 |
|
Other funds holding ELV
Stevens Capital Management's ELV Position: Q3 2024 in Review
Stevens Capital Management sold out of Elevance Health (ELV) in Q3 2024, closing a stake of 682 shares — an estimated $370K sold.
Stevens Capital Management first reported a position in ELV in Q1 2014 and held it in 27 quarters. The position peaked at $28.1M in Q4 2014. 1,693 funds tracked by Wall St. Rank hold ELV as of Q3 2024.
- Stevens Capital Management reported no remaining Elevance Health position as of Q3 2024 after selling out during the quarter.
- Stevens Capital Management sold 682 Elevance Health shares in Q3 2024, an estimated $370K.
- Stevens Capital Management first reported a position in Elevance Health in Q1 2014 and held it in 27 quarters.
- Stevens Capital Management's Elevance Health position peaked at $28.1M in Q4 2014.
- 1,693 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.
Based on Stevens Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.